INO logo

Inovio Pharmaceuticals, Inc.

INO

INO: Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

more

Show INO Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of INO by members of U.S. Congress

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by INO's directors and management

Government lobbying spending instances

  • $60,000 Jul 18, 2023 Issue: Health Issues
  • $60,000 Apr 20, 2023 Issue: Health Issues
  • $130,000 Jan 20, 2023 Issue: Health Issues
  • $140,000 Oct 20, 2022 Issue: Health Issues
  • $140,000 Jul 20, 2022 Issue: Budget/Appropriations Health Issues
  • $150,000 Apr 20, 2022 Issue: Budget/Appropriations Health Issues
  • $60,000 Jan 20, 2022 Issue: Budget/Appropriations Health Issues Defense
  • $30,000 Jan 14, 2022 Issue: Health Issues
  • $60,000 Oct 20, 2021 Issue: Health Issues Defense Budget/Appropriations
  • $30,000 Oct 14, 2021 Issue: Health Issues
  • $60,000 Jul 20, 2021 Issue: Health Issues Defense Budget/Appropriations
  • $30,000 Jul 14, 2021 Issue: Health Issues
  • $60,000 Apr 26, 2021 Issue: Health Issues Budget/Appropriations Defense
  • $30,000 Apr 22, 2021 Issue: Health Issues
  • $30,000 Jan 11, 2021 Issue: Health Issues
  • $30,000 Oct 18, 2020 Issue: Health Issues
  • $30,000 Jul 07, 2020 Issue: Health Issues
  • $10,000 Jan 21, 2020 Issue: Pharmacy
  • $30,000 Oct 14, 2019 Issue: Pharmacy
  • $30,000 Jul 12, 2019 Issue: Pharmacy
  • $30,000 Apr 17, 2019 Issue: Pharmacy
  • $30,000 Jan 08, 2019 Issue: Pharmacy
  • $30,000 Oct 09, 2018 Issue: Pharmacy
  • $30,000 Jul 18, 2018 Issue: Pharmacy
  • $30,000 May 23, 2018 Issue: Pharmacy
  • $30,000 Jan 10, 2018 Issue: Pharmacy
  • $30,000 Oct 12, 2017 Issue: Pharmacy
  • $30,000 Jul 14, 2017 Issue: Pharmacy
  • $10,000 Apr 20, 2017 Issue: Pharmacy
U.S. Patents

New patents grants

  • Patent Title: Vaccines for recurrent respiratory papillomatosis and methods of using the same Sep. 05, 2023
  • Patent Title: Intradermal injection device Aug. 15, 2023
  • Patent Title: Method and device for minimally invasive in vivo transfection of adipose tissue using electroporation Jun. 27, 2023
  • Patent Title: Vaccines against coronavirus and methods of use May. 30, 2023
  • Patent Title: Hand-held electroporation device May. 23, 2023
  • Patent Title: Tolerable and minimally invasive skin electroporation device Jan. 31, 2023
  • Patent Title: Electroporation device and injection apparatus Oct. 18, 2022
  • Patent Title: Cancer vaccines targeting prame and uses thereof May. 24, 2022
  • Patent Title: Cancer vaccines targeting lemd1 and uses thereof May. 24, 2022
  • Patent Title: Device and method for single-needle in vivo electroporation May. 17, 2022
  • Patent Title: Minimally invasive dermal electroporation device Apr. 05, 2022
  • Patent Title: Electroporation device having a battery pack with power switch Apr. 05, 2022
  • Patent Title: Cancer vaccines targeting muc16 and uses thereof Feb. 01, 2022
  • Patent Title: Cancer vaccines targeting mesothelin and uses thereof Oct. 26, 2021
  • Patent Title: Cancer vaccines targeting boris and uses thereof Oct. 26, 2021
  • Patent Title: Multiple tissue layer electroporation applicator and device Aug. 24, 2021
  • Patent Title: Electroporation device with detachable needle array with lock-out system Jul. 27, 2021
  • Patent Title: Intradermal jet injection electroporation device Jun. 08, 2021
  • Patent Title: Cancer vaccines and methods of treatment using the same May. 18, 2021
  • Patent Title: Oral mucosal electroporation device and use thereof Feb. 02, 2021
  • Patent Title: Miniminally invasive dermal electroporation device Jun. 02, 2020
  • Patent Title: Vaccines for human papilloma virus and methods for using the same Mar. 19, 2019
  • Patent Title: Vaccines for human papilloma virus and methods for using the same Mar. 12, 2019
  • Patent Title: Wt1 vaccine Mar. 05, 2019
  • Patent Title: Oral mucosal electroporation device and use thereof Nov. 13, 2018
  • Patent Title: Dna antibody constructs and method of using same Oct. 02, 2018
  • Patent Title: Vaccines having an antigen and interleukin-23 as an adjuvant Jun. 06, 2017
  • Patent Title: Cross-protective arenavirus vaccines and their method of use Sep. 20, 2016
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of INO in WallStreetBets Daily Discussion

INO News

Recent insights relating to INO

CNBC Recommendations

Recent picks made for INO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in INO

Corporate Flights

Flights by private jets registered to INO